Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 970 products on this category.

Product data	Purity	Price range	Estimated delivery
Olaparib Impurity 30 REF: 4Z-O-032032CAS: 1460272-52-9	- - -	To inquire	Tue 04 Mar 25
Lenvatinib Impurity 13 REF: 4Z-L-124017CAS: 417724-81-3	- - -	To inquire	Tue 04 Mar 25
Tamoxifen Citrate REF: 4Z-T-015CAS: 54965-24-1	- - -	To inquire	Tue 04 Mar 25
Enzalutamide Impurity 60 REF: 4Z-E-068074CAS: 1332524-01-2	- - -	To inquire	Tue 04 Mar 25
Nintedanib Impurity 9 (Intedanib Impurity 9) REF: 4Z-N-066023	- - -	To inquire	Tue 04 Mar 25
Lenvatinib Impurity 2 REF: 4Z-L-124003	- - -	To inquire	Tue 04 Mar 25
Nintedanib Impurity 68 Trifluoroacetate (Intedanib Impurity 68 Trifluoroacetate) REF: 4Z-N-066002	- - -	To inquire	Tue 04 Mar 25
Olaparib Impurity 13 REF: 4Z-O-032015CAS: 763111-47-3	- - -	To inquire	Tue 04 Mar 25
Nintedanib Ethanesulfonate (Intedanib Ethanesulfonate) REF: 4Z-N-066001CAS: 656247-18-6	- - -	To inquire	Tue 04 Mar 25
N-Formyl Palbociclib REF: 4Z-P-196036CAS: 2174002-16-3	- - -	To inquire	Tue 04 Mar 25
Leuprorelin (Leuprolide) EP Impurity B REF: 4Z-PL-414CAS: 112642-11-2	- - -	To inquire	Tue 04 Mar 25
Fulvestrant EP Impurity E REF: 4Z-F-318CAS: 2170200-14-1	- - -	To inquire	Tue 04 Mar 25
Lenvatinib-d4 REF: 4Z-L-124004CAS: 417716-92-8	- - -	1,610.00 €~13,282.00 €	Tue 04 Mar 25
Carfilzomib Impurity 45 REF: 4Z-C-121048CAS: 2049024-77-1	- - -	To inquire	Tue 04 Mar 25
Lenvatinib Impurity 43 REF: 4Z-L-124049CAS: 2143930-77-0	- - -	To inquire	Tue 04 Mar 25
Lenvatinib Impurity 42 REF: 4Z-L-124048CAS: 417719-46-1	- - -	To inquire	Tue 04 Mar 25
Gimeracil Impurity 4 (Cyanuric Acid) REF: 4Z-G-047004CAS: 108-80-5	- - -	To inquire	Tue 04 Mar 25
Nintedanib-13C-d3 (Intedanib-13C-d3) REF: 4Z-N-066020CAS: 656247-17-5	- - -	To inquire	Tue 04 Mar 25
Tamoxifen EP Impurity D HCl (E-Isomer) REF: 4Z-T-0127CAS: 15917-51-8	- - -	To inquire	Tue 04 Mar 25
Folinic Acid EP Impurity B (Mixture of Diastereomers) REF: 4Z-F-068003CAS: 98814-60-9	- - -	To inquire	Tue 04 Mar 25

5mg		To inquire
10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

5mg		1,610.00 €
10mg		2,711.00 €
25mg		4,879.00 €
50mg		8,064.00 €
100mg		13,282.00 €

Cancer treatment

Olaparib Impurity 30

Ref: 4Z-O-032032

Lenvatinib Impurity 13

Ref: 4Z-L-124017

Tamoxifen Citrate

Ref: 4Z-T-015

Enzalutamide Impurity 60

Ref: 4Z-E-068074

Nintedanib Impurity 9 (Intedanib Impurity 9)

Ref: 4Z-N-066023

Lenvatinib Impurity 2

Ref: 4Z-L-124003

Nintedanib Impurity 68 Trifluoroacetate (Intedanib Impurity 68 Trifluoroacetate)

Ref: 4Z-N-066002

Olaparib Impurity 13

Ref: 4Z-O-032015

Nintedanib Ethanesulfonate (Intedanib Ethanesulfonate)

Ref: 4Z-N-066001

N-Formyl Palbociclib

Ref: 4Z-P-196036

Leuprorelin (Leuprolide) EP Impurity B

Ref: 4Z-PL-414

Fulvestrant EP Impurity E

Ref: 4Z-F-318

Lenvatinib-d4

Ref: 4Z-L-124004

Carfilzomib Impurity 45

Ref: 4Z-C-121048

Lenvatinib Impurity 43

Ref: 4Z-L-124049

Lenvatinib Impurity 42

Ref: 4Z-L-124048

Gimeracil Impurity 4 (Cyanuric Acid)

Ref: 4Z-G-047004

Nintedanib-13C-d3 (Intedanib-13C-d3)

Ref: 4Z-N-066020

Tamoxifen EP Impurity D HCl (E-Isomer)

Ref: 4Z-T-0127

Folinic Acid EP Impurity B (Mixture of Diastereomers)

Ref: 4Z-F-068003